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Objectives. This study was designed to anatyze the incidence 
and determinants of complications and longterm wrvivat in sinus 
node disease treated with atrial pacing. 
Rockground. Knowledge of ,ho natural history of sinus “ode 
disease trealod will, diPrent pacing modes is imp&eel, and 
euntruverw etiirts wardine the optimal pacemaker theraw. 
Methods. A con&utive&ios & 213 &ientr with sink nade 
direare initially treated with atriat pacing was studied for a 
median f&w-up period of 60 months. The end pints studied 
were permanent at&d fibrillation. high grade utriorentricutar 
(AVV) bloch, P wave undersenaia, pacing mode change, reopra. 
tion and death. Several prognostic lacturs were evaluated slatis. 
ticully and the survival rate was eomparod aith that of a malrhed 
genera, population. 
Rcrulrs. The i”eide”re rate of permanent atiat ~brU,a,io” 
during follow-upwas 7% (1.4%/yr~r). The risk of thisarrhythmia 
increased substathdty with age 270 years at pacemaker imptan- 
Wan. OtUy 2 of the IS patients ah” developed permnn~nt atria, 
Rhrtllation required ventrieutar peeing. High grade AV hlork 
In symptomatic sinus node disease. syncopal attacks and 
other cerebd mzifestatiom of brzdycardia are effectively 
controlled by ventricular(l-7). strial(7-IOI or dual-chamber 
pacing (61. However, ventricular pacing may adverss’y 
a&c, hemcdynamics (11.12). sometimes resulting in the 
cardiovascular symptoms and signs known as the “pace- 
maker syndrome” (13.14) producing congestive heart hiiure 
(15.16). Earlier studies comparing trexments in sinus “ode 
disease have indicated lower incidence rates of congestive 
heart failure (17-19). permanent atrial fibrillation (17-20) and 
possibly systemic embolism (7.20) with arrial than with 
ventricular pacemaker treatment. These lower rate, appear 
,O influence muriaiiiy during long-term follow-up (18.19L 
After implamalion of an atrial-inhibited pacing system. 
pacemaker treatment may be jeopardized by the following 
complications: pernmne”, atrial fibrillation. rendering the 
in patients with eomplrte bundle bra”& h?+ck or hifaswulsr 
block 135%) than i” patirntr without r!xh candurtio” distur- 
bances (b%,. 
A chance Lo vrntrteular or du&chamber stimulatmn wil( 
“oc~ssw in 14% of all patients. orimwilv beawe of ewlv lead 
The rurviral rutcs af 97% at 1 year, 89% at 5 years and 72% 
at IO years did not di&r stgni6xanily frrom those of u ma!ched 
general population. 
Conclusiuns. In stnus nude disease, atrial pacing can he 
,ueeessf”Uy applied during hmg.,erm followup. Pa,ien& with 
~.,“w,PIP hundh hranrh or hi,a_&,ds, Mock in additian tn &US 
nod; disese &mld initially receive a dual-ehamkr pacemaker, 
hut routine applieatii” ol du&rhnmher dimulation does not 
appear to he sarran,fd. 
(J Am CO,, CurdiO, 1992;20:633-9, 
atria incapable of stimulation: high grade htrioventricular 
(AV) b!ock; and technical problems such as lead dislodg- 
ment. exit block and P wave undersensing. These complir- 
lions may result in a need for reoperation. possibly wiib a 
change to ventricular or dual-chamber pacing, and may 
influence prognosis. 
We present Iie long-tan follow-up findings in a conrec- 
utive series of 213 patients with atrial pacing for sinus node 
disease. The aims of the study were to I) invest&are the 
incidence of the complications just cited and the resulting 
need fur reoperation and change of pacing mode: 2) identify 
patients a, risk of such complications by using variables 
know” at pacemaker implantation: 3) compare the long-term 
survival of padents with sinus node disease treated with 
atrial pacing with that of an age- and gender-matched general 
population: and 4) identify determinants of survival in these 
patients. 
Methods 
Sludy patients. Since 1979. atrial-inhibited pacing has 
bee” the freatmen, of choice for symptomatic sinus “ode 
disease at our institution. The indication for pacemaker 
implantation was the ocwrrcnce of cerebral symptoms such 
as syncope and dizzinsss with documeiiled sinus bradycar- 
dia or smus arrrst. including bradycardia aggravated by 
antiarrhglhmic drugs during treatment of the bradycardia- 
tachycsrdm syndrome. Permanent atrial pacing was consid- 
cred to be contraindicated in patients with recorded sponta- 
neous second- or third-degree AV blocK as well as second- 
degree Wenckebach block at an atrial pacing rate of <I20 
impulseslmin during pacemaker implantation. Slight pralan- 
gation of the PQ intewal (up to 240 ms), fascicular block, 
bundle branch block and bifascicular block (complete right 
bundle branch blow togrther with fascicular block) on the 
rest eleiaocardiogram (EC@ were not regarded BS contra- 
indications. Patients with a diagnosis of carotid sinus syn- 
drome wre not treated with atrial pacing. 
During the IO-year period from &gud 1979 to July i989. 
alriai-inblotted pacemakers were implanted in 213 patients at 
our institution. Patient charactetistics are given in Table 1 
and the studv delimtions in Table 2. Clinical findines in some 
of these pa&s have been reported previously (i7.18). 
Pacemaker rystems and measurements at implantation. 
Initially, endocardial swew-in leads were used, and I9 
patients received such leads. Endocardial passive fixation 
leads of dXewit ??=!g.nr ?ve:e tmplanted in the other 194 
patients. A! pxem~krr imp!ar:s:ion, a unipolar recording of 
the inlraatrial P wave through the permanent pacing lead was 
obtained wth use of a Siemens-Elema Mingograph ink jet 
ECG recorder. The peak to peak amplitude was measured. If 
amplitude variations wre seen. the mean amplitude was 
calculated from five consecutive beats. The voltage pacing 
threshold was determined with a Medtronic or Intermedics 
pacing systems analyzer through stepwise lowenng of the 
output until loss of capture occurred; an impulse duration of 
0.5 or 0.75 ms was used. lnrraatrial P waves and pacmg 
thresholds at implantation are shown in Table 3. In 207 
patients (97%). pulse generators permitting noninvasivc de- 
terminalion of voltage pacing threshold (the Vario principle) 
(21) were implanted. 
Folbnwp. If no immediate complications occurred. pa- 
tients were discharged from the hospital a few days after the 
pacemaker implantation. Routme follow-up consisted of 
outpatient visits at i, 3 and 6 months after uperation and at 
L-month intervals thereafter. An ECG was recorded, and the 
stimulation threshold was determined noninvasively if pos- 
sible. If a patient repotted dizziness. syncopal attacks or 
symptoms indicating previously undiagnosed arrhythmias, a 
24-b Halter record& was oh&d aid repeated if neces- 
sary. Individualized antiarrhythmic drug treatment \uas 
given to patients wi!h sapraventricular tachyarrhythmias 
persisting after pacemaker implantation. 
The follow-up period for each patieni was defined as the 
time interval between pacemaker implantation and the latest 
follow-up visit. For patients who died durblg follow-up. 
information regarding the cause of death was obtained from 
hospital records and the death certificate and autopsy report 
(if available): the survival time between pacemaker implan- 
tation and death WBE calculated. Elective pulse generator 
exchange due to battery depletion-with maintenance of 
atrial w&w-was not classified as a “reowration.” 
St&s&l methods. The following end &nts were stud- 
ied: permanent atrial fibrillation, high made AV block. P 
wave under*ensing, pacing mode cc&c, reoperation and 
death. For patients still alive at the last follow-up date, the 
survival time was censored at that point. The time variables 
corresponding to the other end points were censored either 
at death or at last follow-up if these end points had not 
occurred earlier. 
Several prognwtic factors (Table 4) were evaluated by 
Table 3. Electrophysiolopic Data at Pacemaker Implantation 
?hc only variable significantly r&ted to permanent at&J 
means of log-rank tests and Kaplan-Meier surviu! curves 
with 95% &idence intervals. These curves should be 
interpreted as estimates of the “parual survival function” 
Figure 1. Pyxvlion of &ems 4ith atrial pacing friuc UC Ihe 
122) for the time up to the corresponding end poinl in the 
d~ikicnt cod pant wents as a function of time ipan~al survivai 
hypothetic absence of death. Pntient survival was aiw 
function1 lheavr line). The thinner lines show the 95% confidence 
IimK A, Prrmanent atria1 fibrillation. 8. High grade attiovcntricu- 
analyzed with a Cox proportional haLards model to identify lar biuck C. Pacing mode change. D. Rcoptralian. 
gbrillation was advanced age at pacemaker implantation 
to = O.W7k In uatients 870 wars of see. the aooroximate 
incidence rate of permanent a&l fibrtllr&n was 2,7%iyear, 
whereas it was onlv tl.:%/vear m oatients ~70 “ears old. The 
presence of supra&lric&r t&arrhythmias before pace- 
maker implantation was not a significant predictor tp = 
0.27). Two (13%) of these 15 patients developed significant 
bradycardia during continued follow-up and required reap 
eration to ventricular-inhibited (VYtt mode. The remaining 
13 patientr have been followed up for 23 5 18 months after 
the occumnce of permanent atrial fibrillation without evi- 
dence of bradycardia. 
Atrtaventricular block. Eighteen patients (8.5%) devel- 
oped high grade AV block during follow-up (Fig. 19). This 
group mcluded the two patients with perrrranent atrial fibril- 
lation and bradycardia. Eleven patients prescnrcd with diz- 
ziness. fatigue or general discomfort. four had syncopal 
attxks and three had no symptoms from the bradycardia. 
The presence of bundle branch or fascicular block on the 
preoperative ECG emerged as the only significant predictor 
of subsequent high grade AV block (p = 0.01). However, 
subgroup analysis revealed that fasL;cular block alone was 
not associated with au increased risk of AV block. whereas 
this risk was considerably higher for patients with complete 
left or right bundle branch block or bihsciculnr block (Table 
5). Thus, 6 (35%) of the 17 patients with complete bundle 
branch or bifascicular block developed high grade AV block 
compared with 12 (6%) ol 196 parients without bundie 
branch or brfascicular block (p < 0.001). Eight patients had 
a PQ interval of 220 to 240 ms on the preoperative ECG; 
none developed high grade AV block. The Wenckebach 
point at pacemaker implantation was of no use as a predictor 
of subsequent high grade AV block. All patients with this 
complication had a Wenckehach point 8130 impulseslmin 
and 12 of the IS potients had a Wenckebach point 2150 
impulseslmin. Twelve patients received a dual-chamber 
pacemaker: the remaining six a ventricular-inhibited unh. 
Pwavcundersensing. This phenomenon was documented 
in nine patients (4.2%). 11 was transient in four of these nine 
patients. In the remaming five. reoperation was not deemed 
necessary because the undersensing did not severely drsturb 
the pacemaker therapy. Noneofrhe variablesterled showed 
a . ..edrctive value regarding postepsrarive P wave under- 
sensing: thus, it was not related to the P wave amplitude at 
Table 1. tndicar;onr for Surgical Kevirion Wrth Msinrenancc ot
Atrral Pacing 
implantation , = 0.21) or the lead fixation principle (active 
or passive; p = 0.42). 
Revisions with maintenance of ntrial pacing. Fifteen pa- 
tients (7%) underwent one or more surgical interventions 
with maintenance of atrial-inhibited pacing (excluding elec- 
tive pulse generator exchanges) for the reasons shown in 
Table 6. Eight reoperations were undertaken because of 
complications unrelated to the atrial pacing mode. Three of 
the patients required two revistons and one had three oper- 
ations. In two patients a” initial revision was followed by a 
mode change. 
Made ehangc. In 30 patients (14%). the Pacing mode was 
changed during follow-up (Fig. IC) for the reasous listed in 
Table 7. In eight (3.8%) of these patients, the atrial pacing 
lead was dislodeed to the right ventricle immediatelv after 
pacemaker imp~ntation. Th;ee of these eight patiebts had 
stable ventricular pacing and required no reoperation; in the 
remaining five, the lead position was surgically adjusted to 
ensure normal ventricular stimulation. 
Twenty-two patients (10%) underwent mode change for 
reasons other than lead dislodgment, primarily for high grade 
AV block 01 = 18). Fourteen of the 22 patients received a 
dual-chamber and 8 a ventricular-inhibited system. In all, 40 
patients (19%) had a surgical intervention of smne kind 
during follow-up (excluding elective pulse generator ex- 
change due to battery depletion) (Fit. tD). 
Table 7. Indications for Pacemaker Mode Change 
Figure 2. Survival during rmw-up ;hPa”y line). The thinner liner 
shaw the 95% confidence limits of the observed surwal. DOQ show 
the expected survival in a Swedish population matched for age and 
gender. 
Survival. Thirty-five patients (17%) died during follaw- 
up. The survival curve for the patients is show in Figure ?. 
For the patients with sinus node disease, the survival rate 
was 97% at I “ear. 8% at 5 “ears and 725 at IO “ears. The 
survival rate in this group did not differ signi&nrly from 
that of a Swedish age- and gender-matched general pof,ula- 
lion. in which the corresponding survival probabilities were 
97%. 82% and 63%. respectively. 
The cauw of death are listed in Table 8. Seven patients 
died suddenly. At the time of death, four OF these had atrial. 
two had ventticular and one had dual-chamber pacing. Sin of 
the patients with sudden death had manifestations of isch- 
emit heart disease (angina pectoris or myocardiat infarction) 
before death. Autopsy was performed in three of the seven 
patients. All three had coronary arteriosclerosis: autopsy 
evidence of acute myocardial infarction was found in one 
and of extensive previous myocardial infarctions in another. 
Cox regression analyses revealed the following indepen- 
dent significant risk factors for death: advanced age at 
pacemaker implantation (relative risk 3.4: p = 0.003). con- 
gestive heat* failure (relvive risk 5.4: p < O.WtL ischemic 
heart disease (relative :isk 3.3: p = 0.003). bradycardia- 
cauie No. 
tachycard~a syndrome Welab ‘e risk 2.3: p = 0 031 and 
bundle branch or fasciculer block on the meowrative ECG 
(relatwc n,k 2 8: p = O.WB) 
Further analyses showed :hat the higher mortali!y rate in 
thox airh the bradycardia-tachycardia syndrome was not 
cau\cd by f&al stroke (the cause of death in I of the 22 
patients alth thts syndrome who dted was a cerebrovascular 
acc!denrI. The increased mortality rate seen in the group 
wtb bundle branch and fascicular black could wt be attrib- 
utcd to a high ntcidence of sudden death because only 2 of I I 
deaths were sudden. Both of these patients with sudden 
death had undereone mode chance before death (one to 
wntricular and o& to dualshamber pacmg). Thus. death 
was not caused by !he sudden development of high pdc AV 
block. 
Discussion 
Rmonal choice of the appropriate pacing mode for a 
pattent with amus node disease demands knowledge of the 
possible effects of different stimulation modes on cardiovas- 
cular physmlogy, morbidity and mortality. There is accumu- 
lating evidence (17-20.25) that ventricular-inhibited pacing 
in sinus node disease is potentially deleterious and not a 
first-line treatment. However, the question has remained 
whether atrial or dualxhamber pacing should be the first 
choice. The present resalts with atria.1 pacing-t--the least 
elabomie of the pacing modes providing AV synchrongP 
may prowde a rational basis for stimulation mode selecnon. 
Atria: fibrillation. In earlier studies (17.18) of a smaller 
number of atrially paced patients with sinus node disease, 
we found an incidence rat; of pemtanettt atrial fibrillation of 
3.4% after approximately 2 years and 6.7% after close to 4 
years of pacmg. The annual incidence rate of approximately 
1.4% in the present report is identical to that reported by 
Sutton and Kenny (20). who presented a collective review of 
several studies comtxising a total of 410 patients with atrial 
pacing and a mean ~ollo&p period of 35.8 months. In our 
study. pc:manent atrial fibrillation was not a major pacing 
problem because only 2 (13%) of the I5 patients with this 
arrhythmia required reopemtion for a change to the ventric- 
ular pdcing mode. 
In studies (5.X.27) of ventricular pacing in sinus node 
disease. preoperative vidence of supraventricular tachycar- 
&as was found to increase the risk of permanent atrial 
fibrillation. One reason for the lack of this association in our 
series may be the relatively small number of patients with 
permene?t atrial fibrillation. which resulted in a fairly low 
statistical power of the prognostic factor evaluation. An- 
other possible explanation is that patients with sinus brady- 
cardia or sinus arrest may later show progession to the 
bradycardia-tachycardia syndrome. with subsequent con- 
version to permanent fibrillation (28). During long-term 
follow-up, some patients may pass through all three stages of 
atrial rhythm. 
Cardioversion was not rouunely attempted in patients 
who developed atnal fibrillation in our scnes. It IS possible Survival. Patients with atrial pacing for sinus node dis- 
that tbzs should be done; howcvc;, we are not aware of any east show the same survival rate as an age- and gender- 
date concerning the long-term results of cardioversion in matched general population, an observation also made by 
sinus node disease with atrial pa&g. Lemke et al. 133) in a study of 100 patients. The average 
Atrioventricular block. An important finding was that patient requiring pacemaker implantation for sinus node 
preoperative complete bundle branch JT bifescicular block disease hns an expected survival far in excess of IO years. To 
considerably increased the risk of subsequent AV biock. reduce the number of pulse generator exchanges necessary 
Whether such conductton defects are a contraindication to because or baltery depletion, minimizatton of pacemaker 
atrial De&I! has been uncertain. Bellinder et al. (91 found energy enpcnditure is therefore an important consideration - 
complete bundle branch block in 5 of52 patients receiving an 
atrial pacemaker; progresston to high grade AV block did not 
occur in any of these patients during follow-up (mean 48 
months for the total study group). Kallryd et al. (291 noted 
progression to second-degree AV block in I of 5 patients 
with bundle branch block m their series of 66 patients with 
an atrial pacemaker followed up for a mean of 32 months. 
Our results in the present. larger group of patients with a 
longer follow-up period indicate that dual-chamber pacing 
should be the primary choice for patients with bundle branch 
or bifascicular block. Our data regarding a slight prolonga- 
tion of the PQ interval are in agreement with those of both 
Bellinder et ai. (9) and Kallryd et al. (291, indicating a low 
risk of high grade AV blocI< for these pelients. 
If patients with complete bundle branch or bifascicular 
block are excluded, the yearly mcidcnce rate of high grade 
AV block is reduced from I .g% to approximately 1.2%. This 
raw is somewhat higher than the median annual incidence 
rate ofO.b% reported in the extensive review of 28 studies of 
atrial pacing presented by Rosenqvist and Obel (30) 
The intraoperative Wenckebach point was not a useful 
predictor of subsequent high grade AV block. The auestion 
ihus arises whether atrial pacing may be employed in pa- 
tients with a Wenckebach point <I20 impulsesimin. Our 
present data do not anwcr this questton but support the 
view that thcrc i5 little evidence of the value of Wenckebach 
point determination in clinical pacing. It remains to be 
proved whether other electrophysiologic tests performed at 
the time of pacemaker implantation are of value in identify- 
ing patients at risk of high grade AV block during chronic 
atrial pacing. 
Modechance. The most important cause of mode chanae 
during follow-up was high grade AV block 118 patieots).if 
the 17 patients with bundle branch or biFdscicular block had 
been excluded from atrial pacing. the number of patients 
rrqniring mode change because of AV block would have 
been reduced to I2 and the total incidence of mode change 
during follow-up 10 12%. 
A total of I I leads (5.2%) dislodged ix!edie!e!y after 
operation. In eight cases. we chose to leave or place the 
dislodged lead in the ventricular position. The reason for this 
was generally a difficult placement of the clcctrode in the 
atrium: all of these wtients had zxassive fixation leads. 
in this patient group. 
Sudden death in a patient with an atrial pacemaker may 
theoretically be caused by abrupt high grade AV block. 
However, only four of the seven patients who died suddenly 
were being treated with atrial-inhibited pacing at the time of 
death. Furthermore. stud& (5,26,34) in ventricular pacing 
for sinus node disease have reported that between 17% and 
24% of deaths during follow-up are sudden, rates very 
similar to the incidence of sudden death (19%) in our series. 
Together with the high prevalence of known ischemic heart 
disease in the patients who died suddenly, these data 
strongly suggest ihat a venlricular tachyalTbythmia was the 
cause of death. 
Ischemic heart disease and congestive heart failure were 
expected risk factors for death. However. we have no 
definite explanation for the significant negative influence of 
supraventricular tachyarrhythmias and bundle branch or 
fascicular block on survival. It can be speculated whether 
these aomtrent risk fxtorr. reflect mvocardial deeenerative 
changes having negative pro&:tostic &fects. _ 
Stalistical considerations and limitations. The statistical 
methods for analyzing censored data assume that the cen- 
soring mechanism is independent of the end point; this 
assumption may be discussed for censoring by death. Only 
17% of the patients died. however, and for some of them the 
end point under study may have occurred earlier. Moreover. 
250% of deaths were not associated with hart disear:. so 
the possible deviations from independent censoring should 
not have had a great intluence on the results. Despite the 
laze number of patients in this long-term follow-uv study. 
tb; different eni points were reached in a fairly s&II 
number of cases. The statistical power of the prognostic 
faclor analyses is therefore limited, and effects of these 
factors on the end points may have gone undetected. 
Atrlalordual-chamber pacing.? The alternative treatment 
in symptomatic sinus node discax is dual-chamber pacing 
(DDD or DDI). It is crucial to determine whether all or some 
patients with sinus node disease fare better with dual- 
chamber [bar. with atrial pacing. and the present data should 
bc iatcrp;e:ed with tbi. ii, ilLi. 
Dual-chamber pacing should obviously be chosen for 
patients with sinus node disease and complete bundle branch 
or bifascicular block. In patients without such conduction 
disturbances. the auestion is more comolex. The incidence 
Modern screw-in leads generally ha;e a lower dislodgment of permanent atrial fibrillation and P wave undersensing 
rate (31.32) and the “se of such leads may thus reduce the would not have been modified by the addition of a ventric- 
need for mode change during atrial pacing. ular lead. The surgical revisions directed 10 the atrial lead, 
the pulse @“erator and the pacemaker pockrt ITablr 61 
would have bee” “ecewary to maintain functmnal dval- 
chamber pacing as well. Not countmg the patients rith 
complete bundle branch or bifaxicular block. mode chilnge 
was “ece~sar:~ for various reawns in 23 patients. ?I of whom 
needed a reopeniio”. These ?I patients (11%) would not 
have required additional surgery had they znitlally recewed d 
duzd-chamber sy~!em. However. the need for reoprrat!~” 
caused by ventricular lead problems in long-term dual- 
chamber pacing must ah be taken into account q)ne rsce”t 
large study (35) showed a 6% incidence rate of ventr~ular 
lead failure during 5 yean of dual-chember pacing: another 
(36) found a 3.5% incidence mte during a mean follow-up 
period of 2.5 years. In a study of a total of 551 endacardial 
ventricular leads, Maseki et al. 1371 found ventricular lead 
failure rates of 4% (sd~cone leads) and IO% tpolyurerhanc 
leads) after 5 yews. Theoretically, the total “umber of 
reoperaiions would therefore have bee” only nliphtly lower d 
all our patients had initially received a dual-chamber pace- 
maker. Whether a slight reduction in rhe “umber of reaper- 
ations during follow-up outweighs the cov~derably higher 
costs (381, the somewhat more complicateu implantation 
procedure, the risk of pacemaker-related arrhythmias 139) 
and the shorter life spa” of dual-chamber pacemakers is a 
matter of opinion. The use of atrial-inhibited pacing in Gnu, 
node disease is cenainly justifiable. 
